• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [23537 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2009     The Swedish Council on Health Technology Assessment (SBU) [Transcranial magnetic stimulation in treating depression]
2009     NIHR Health Technology Assessment programme Dabigatran etexilate for the prevention of venous thromboembolism in patients undergoing elective hip and knee surgery: a single technology appraisal
2009     Institute for Clinical Effectiveness and Health Policy (IECS) Detection of deamidated gliadin peptides for the diagnosis of celiac disease
2009     HAYES, Inc. Saw palmetto for benign prostatic hyperplasia
2009     NIHR Horizon Scanning Centre (NIHR HSC) Afamelanotide for erythropoietic protoporphyria and congenital erythropoietic porphyria
2009     Committee for New Health Technology Assessment (CNHTA) [Malaria antigen, rapid(target Ag:Aldolase,Histidine-rich protein-2)]
2009     NIHR Health Technology Assessment programme A systematic review of presumed consent systems for deceased organ donation
2009     Institute for Clinical Effectiveness and Health Policy (IECS) Growth hormone in short children born small for gestational age
2009     NIHR Horizon Scanning Centre (NIHR HSC) Alipogene tiparvovec (AMT-011, Glybera) for lipoprotein lipase deficiency
2009     Committee for New Health Technology Assessment (CNHTA) [F12 gene, mutation[sequencing]]
2009     Institute for Clinical Effectiveness and Health Policy (IECS) Immunoassay D-Dimer test as marker of venous thromboembolism
2009     NIHR Horizon Scanning Centre (NIHR HSC) Clopidogrel (Plavix) for neonates and infants with cyanotic congenital heart disease who have undergone a palliative shunt procedure
2009     Committee for New Health Technology Assessment (CNHTA) [F7 gene, mutation[sequencing]]
2009     Institute for Clinical Effectiveness and Health Policy (IECS) Serum Anti-Mullerian Hormone (AMH) as ovarian reserve marker
2009     NIHR Horizon Scanning Centre (NIHR HSC) Ofatumumab for fludarabine-refractory chronic lymphocytic leukaemia - second or third-line
2009     Committee for New Health Technology Assessment (CNHTA) [IL2RG gene mutation analysis]
2009     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Systematic review of efficacy and safety in Cyberknife radiosurgery: indications and results in the treatment for intra and extracranial lesions]
2009     NIHR Horizon Scanning Centre (NIHR HSC) Omalizumab (Xolair) for severe persistent allergic asthma in children
2009     Committee for New Health Technology Assessment (CNHTA) [SNCA Gene Mutation Anaysis]
2009     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Laparoscopic hysterectomy and lymphadenectomy efficacy and safety in endometrial cancer]
2009     University of York A systematic review of risk prediction rules in febrile neutropenic episodes in children and young people undergoing treatment for malignant disease (Protocol for a systematic review)
2009     NIHR Horizon Scanning Centre (NIHR HSC) Silodosin for benign prostatic hyperplasia
2009     Committee for New Health Technology Assessment (CNHTA) [GFAP gene, mutation[sequencing]]
2009     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Photodynamic therapy effectiveness and safety in nonmelanoma skin cancer]
2009     Haute Autorite de sante (HAS) [Assessment of breast implants, tissue expanders and external breast prostheses]
2009     HAYES, Inc. Spinal cord stimulation for relief of neuropathic pain
2009     Committee for New Health Technology Assessment (CNHTA) [Continuous femoral nerve block]
2009     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Photodynamic therapy effectiveness, safety and cost-effectiveness in oesophagus cancer and Barrett oesophagus treatment]
2009     Medical Advisory Secretariat (MAS) Specialized multidisciplinary community-based care series: summary of evidence-based analyses
2009     HAYES, Inc. Stereotactic radiosurgery for arteriovenous malformations and intracranial tumors
2009     NIHR Horizon Scanning Centre (NIHR HSC) WATCHMAN left atrial appendage (LAA) closure device for non-valvular atrial fibrillation (AF)
2009     Committee for New Health Technology Assessment (CNHTA) [Tonsillectomy with coblation]
2009     Medical Advisory Secretariat (MAS) Diabetes strategy evidence platform: summary of evidence-based analyses
2009     NIHR Horizon Scanning Centre (NIHR HSC) Agento I.C for ventilator associated pneumonia
2009     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Fast-track surgery and enhanced recovery after surgery (ERAS) programs
2009     Committee for New Health Technology Assessment (CNHTA) [Pressure wire]
2009     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Appropriateness use standards for health technologies : appropriate admission explicit criteria for heart failure (HF)]
2009     Medical Advisory Secretariat (MAS) Prevention and management of pressure ulcers: summary of evidence-based analyses
2009     NIHR Horizon Scanning Centre (NIHR HSC) Radachlorin photodynamic therapy for basal cell carcinoma
2009     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Endoscopic thoracic sympathectomy
2009     Committee for New Health Technology Assessment (CNHTA) [TruScreen - cervical cancer screening system]
2009     Medical Advisory Secretariat (MAS) Intraocular lenses for the treatment of age-related cataracts: an evidence-based analysis
2009     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Neoadjuvant radiochemotherapy for rectal cancer
2009     Committee for New Health Technology Assessment (CNHTA) [MUTYH gene mutation[Sequencing]]
2009     Medical Advisory Secretariat (MAS) Phakic intraocular lenses for the treatment of low to high refractive errors: an evidence-based analysis
2009     Belgian Health Care Knowledge Centre (KCE) Interspinous implants and pedicle screws for dynamic stabilization of lumbar spine: Rapid assessment
2009     Committee for New Health Technology Assessment (CNHTA) [ELA2 gene point mutation analysis]
2009     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Effectiveness, safety and indications of da Vinci Surgical System]
2009     Medical Advisory Secretariat (MAS) Optical coherence tomography for age-related macular degeneration and diabetic macular edema: an evidence-based analysis
2009     Committee for New Health Technology Assessment (CNHTA) [NTRK1 gene point mutation analysis]
2009     Haute Autorite de sante (HAS) [Assessment of drug-eluting stents]
2009     Medical Advisory Secretariat (MAS) Point-of-care international normalized ratio (INR) monitoring devices for patients on long-term oral anticoagulation therapy: an evidence-based analysis
2009     Committee for New Health Technology Assessment (CNHTA) [CoaguChek XS PT TEST]
2009     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Systematic review and cost-effectiveness analysis of radiofrequency ablation in liver tumors and metastases]
2009     Medical Advisory Secretariat (MAS) Oral appliances for obstructive sleep apnea: an evidence-based analysis
2009     NIHR Health Technology Assessment programme Adalimumab for the treatment of moderate to severe psoriatic arthritis
2009     Committee for New Health Technology Assessment (CNHTA) [AMH]
2009     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Assessment of the re-designed diagnosis process for colorectal cancer]
2009     Medical Advisory Secretariat (MAS) Fenestrated endovascular grafts for the repair of juxtarenal aortic aneurysms: an evidence-based analysis
2009     Committee for New Health Technology Assessment (CNHTA) [Genotyping of MDM2 SNP309 polymorphism]
2009     Medical Advisory Secretariat (MAS) OHTAC 2009 Progress Report - advancing health: evidence-based advice on health technology
2009     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Efficacy and safety of 64-multislice CT: a systematic review]
2009     Medical Advisory Secretariat (MAS) Intrastromal corneal ring implants for corneal thinning disorders: an evidence-based analysis
2009     Committee for New Health Technology Assessment (CNHTA) [ERCC1 RNA RT-PCR quantification]
2009     Quality Improvement Scotland (NHS QIS ) Is patient self-monitoring (including self-testing and selfmanagement) of oral anticoagulation therapy safe, efficacious and cost-effective?
2009     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Standards for the appropriate use of health technologies. Pharmacological treatment of bipolar disorder]
2009     Penn Medicine Center for Evidence-based Practice (CEP) Early term induction of labor
2009     Committee for New Health Technology Assessment (CNHTA) [RRM1 RNA RT-PCR quantification]
2009     Quality Improvement Scotland (NHS QIS ) Provision of information to patients with long term conditions
2009     Committee for New Health Technology Assessment (CNHTA) [Balloon tamponade for postpartum hemorrhage]
2009     Quality Improvement Scotland (NHS QIS ) A systematic narrative review of quality improvement models in health care
2009     HAYES, Inc. Intravitreal bevacizumab (Avastin; Genentech Inc.) for the treatment of proliferative diabetic retinopathy
2009     Committee for New Health Technology Assessment (CNHTA) [Endobronchial ultrasound/fine needle aspiration]
2009     Quality Improvement Scotland (NHS QIS ) Clinical and cost-effectiveness of self-monitoring of blood glucose (SMBG) for non-insulin treated type 2 diabetes
2009     VA Technology Assessment Program (VATAP) Systematic reviews for localized prostate cancer
2009     The Netherlands Organisation for Health Research and Development (ZonMw) [Cost-effectiveness of two different strategies to implement the NVOG guideline programme on subfertility]
2009     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Is biomedical research a good social investment? The evaluation of the social impact of medical research
2009     HAYES, Inc. Breast-specific gamma imaging (BSGI)
2009     Committee for New Health Technology Assessment (CNHTA) [SurePATH liquid-based cytology test for FNA(fine needle aspiration) specimens]
2009     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Multiple chemical hypersensibility: state of the art on aetiology and treatment
2009     Committee for New Health Technology Assessment (CNHTA) [Antroduodenal manometry]
2009     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Darunavir (Prezista®) for the treatment of HIV-1 infected, treatment-naïve adults in combination with other antiretroviral medicinal products
2009     The Netherlands Organisation for Health Research and Development (ZonMw) [Costs and effects of two modes for disease management of chronic obstructive pulmonary disease (COPD) in general practice. A randomized controlled trial comparing regular nurse practitioner review and self-management education]
2009     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Amotosalen (Intercept) for the inactivation of pathogens in plasma and platelets: usage in Spain
2009     HAYES, Inc. Laparoscopic ileal interposition and sleeve gastrectomy for treatment of type 2 diabetes [REVISED 02.16.09]
2009     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Degarelix (Firmagon®) for the treatment of advanced hormone-dependent prostate cancer
2009     HAYES, Inc. Amyotrophic Lateral Sclerosis (ALS; Lou Gehrig Disease)
2009     Penn Medicine Center for Evidence-based Practice (CEP) Reprocessing of surgical drills
2009     The Netherlands Organisation for Health Research and Development (ZonMw) [Development of organizational interventions to improve compliance with guidelines on depression and anxiety in primary care]
2009     Penn Medicine Center for Evidence-based Practice (CEP) Managing the difficult airway
2009     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Ranolazine (Ranexa®) as add-on therapy for symptomatic treatment of stable angina pectoris
2009     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Emerging technologies (part 2): EU newsletter
2009     HAYES, Inc. Laparoscopic sleeve gastrectomy for super obesity in adults
2009     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Methoxy polyethylene glycol-epoetin beta (Mircera®)
2009     National Evidence-based Healthcare Collaborating Agency (NECA) [Reuse of single-use medical devices: current evidence and regulations]
2009     HAYES, Inc. Breast cancer susceptibility 1 and 2 (BRCA1/2) sequence variant testing for susceptibility to hereditary breast cancer
2009     Agency for Healthcare Research and Quality (AHRQ) Impact of consumer health informatics applications
2009     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Information and communications technologies in CHF management programmes. Organizational challenges and evidence status]
2009     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Mecasermin (Increlex®)
2009     Andalusian Health Technology Assessment Area (AETSA) [Utility of PET-FDG to assess response of breast, oesophagus and lung neoplasms. A systematic review of results after neoadjuvant therapy]